Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin

Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin

Background Intratumoral BCG therapy, one of the earliest immunotherapies, can lead to infiltration of immune cells into a treated tumor. However, an increase in the number of BCG-induced tumor-specific T cells in the tumor microenvironment could lead to enhanced therapeutic effects.Methods Here, we...

Full description

Bibliographic Details
Main Authors: Sara Feola, Manlio Fusciello, Beatriz Martins, Erkko Ylösmäki, Vincenzo Cerullo, Tapani Viitala, Firas Hamdan, Jacopo Chiaro, Leena Ylösmäki, Matthew J Vaughan, Prasad S Kulkarni
Format: Article
Language:English
Published: BMJ Publishing Group 2021-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/7/e002707.full

Internet

https://jitc.bmj.com/content/9/7/e002707.full

Similar Items